Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03750071
Title VXM01 Plus Avelumab Combination Study in Progressive Glioblastoma
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Vaximm GmbH
Indications

glioblastoma

Therapies

Avelumab + VXM01

Age Groups: senior | adult
Covered Countries DEU


No variant requirements are available.